Marijuana Statistics: Use, Addiction & Health Trends

Most patients who come to us do not think of themselves as addicted to marijuana. They say they can stop anytime, they just have not had a reason to. What I actually see in intake assessments is a pattern of daily use that started in mid-adolescence, escalating to high-potency concentrates, and a growing list of things the person no longer does because cannabis has replaced them. The statistics below describe that trajectory at a population level, but I see it one person at a time.

Global Marijuana Use Statistics

Cannabis is the most widely cultivated, trafficked, and used illicit drug worldwide. The United Nations Office on Drugs and Crime estimates that 228 million people used cannabis in 2023, representing approximately 4.5% of the global adult population aged 15 to 64. That figure has risen steadily over the past two decades.

North America carries a disproportionate share of that burden. The United States, Canada, and Mexico collectively account for some of the highest per-capita use rates globally. Western Europe and Australia are close behind, with use rates accelerating in line with decriminalization and legalization trends.

THC potency is a critical part of the global picture that raw use statistics miss. In the early 1990s, seized cannabis averaged roughly 4% THC. By 2023, average potency in US dispensary flower had risen to 15 to 20%, and concentrate products such as dabs and wax regularly exceed 70 to 90% THC. Higher potency directly increases dependence risk and shortens the time between first use and cannabis use disorder.

United States Marijuana Use Statistics 2024 and 2025

The 2024 SAMHSA National Survey on Drug Use and Health produced the most detailed snapshot of American cannabis use to date. Here are the numbers that matter clinically.

61.5 million adults, or 23.4% of the American adult population, used marijuana in 2024. That is not lifetime use. That is use within the past year. For comparison, the same survey recorded cigarette use at approximately 18%, meaning cannabis use has now overtaken tobacco use among American adults for the first time.

44.3 million Americans used marijuana in a typical month in 2024. 64.2 million used it at some point in the year. The gap between those two figures represents tens of millions of people who use occasionally, which is a different clinical profile than the 44 million monthly users.

Lifetime use is even higher. Approximately 133 to 137 million Americans over age 12, close to half the entire population, have used marijuana at least once. That figure matters less clinically than frequency and age of onset, but it explains why stigma around cannabis has largely collapsed in American culture.

How US Marijuana Use Has Changed Over a Decade

The trajectory is steep. Between 2015 and 2024, marijuana use among Americans increased by an estimated 65.2%. Overall illicit drug use rose 54.1% over the same period, meaning cannabis outpaced the broader trend. Rates of substance use disorder involving marijuana were 3.7 times higher in 2024 than in 2015.

Part of this reflects legalization: by 2024, recreational marijuana was legal in 24 states and Washington DC. Part of it reflects perception shifts. Surveys consistently show that public concern about cannabis risk has declined sharply, even as clinical evidence of harm has grown.

Marijuana Addiction Statistics and Cannabis Use Disorder

This is where the numbers get clinically important. Use statistics and addiction statistics are not the same thing, and confusing them leads families to underestimate the problem.

Approximately 30% of people who use cannabis will develop cannabis use disorder (CUD), defined under DSM-5 as a pattern of use causing clinically significant impairment across two or more of eleven criteria in a 12-month period. Those criteria include tolerance, withdrawal, failed attempts to cut down, continued use despite physical or psychological harm, and neglect of major life roles.

In 2024, an estimated 16.4 million Americans met DSM-5 criteria for cannabis use disorder. That figure represents a 3.7-fold increase from 2015. The increase is not fully explained by rising use rates alone. Higher-potency products accelerate the development of tolerance and physical dependence, which shortens the path to disorder.

Cannabis Use Disorder Risk Factors

Age at first use is the single strongest predictor. People who begin using cannabis before age 18 are 4 to 7 times more likely to develop cannabis use disorder than those who start in adulthood. Those who start before age 12 carry roughly twice the risk of developing mental health comorbidities alongside dependence. The adolescent brain, particularly the prefrontal cortex and the endocannabinoid system, is still developing until the mid-20s and is more vulnerable to the neuroadaptive effects of THC on CB1 receptors.

Daily use is the second major risk factor. Among daily or near-daily users, dependence rates climb to approximately 50%. The 5.6% of 12th-graders who report daily cannabis use fall directly into this high-risk category.

Marijuana Use Among Teenagers and Adolescents

Youth marijuana statistics are the ones clinicians watch most closely, because the consequences of early use are disproportionately severe and long-lasting.

The 2025 Monitoring the Future survey recorded that 25.7% of 12th-graders used marijuana at least once in the past year. Daily use among high school seniors sits at 5.6%, meaning roughly 1 in every 20 seniors is using cannabis every day. That number has remained broadly stable for several years despite incremental declines in overall adolescent use.

Nearly 4,200 young people between ages 12 and 20 try marijuana for the first time every day. Approximately 31.4% of all first-time marijuana users in the past year were between ages 12 and 17. Close to 5% of adolescents report first use before age 13.

One critical shift: lifetime marijuana use among 12th-graders has decreased by 20.4% over the past five years, which is genuinely good news. But the adolescents who do use are increasingly using more potent products, more frequently. The public health risk has shifted from breadth to intensity.

Marijuana vs. Cigarettes Among Teenagers

Daily marijuana use now exceeds daily cigarette use across all three secondary school grade levels surveyed. Among 8th-graders, 0.9% report daily marijuana use versus 0.2% for cigarettes. Among 10th-graders, the figures are 3.1% versus 0.3%. Among 12th-graders, 5.6% versus 0.8%. This crossover first appeared in 12th-graders in 2015 and has been consistent since.

Teen Driving and Marijuana

6.3% of teen drivers overall report driving under the influence of marijuana. Among teen drivers who use marijuana, that figure rises to 24.5%. Cannabis is the most commonly detected illicit substance in drivers involved in fatal motor vehicle accidents, present in 21.5% of traffic fatalities. THC impairs reaction time, spatial judgment, and divided attention, all skills that driving depends on.

Marijuana Health Statistics: What the Evidence Shows

The data on cannabis-related health outcomes has grown substantially over the past decade, partly because legalization in research-friendly jurisdictions made studies easier to conduct.

Mental health is the most significant area. Regular cannabis use is associated with a 2-fold increased risk of psychosis, and this relationship is dose-dependent, meaning higher potency and greater frequency of use amplify the risk. The mechanism involves THC’s agonist activity at CB1 receptors in the prefrontal cortex, disrupting dopaminergic signaling in ways that overlap with schizophrenia-spectrum pathology. The link between cannabis and psychosis is one of the most replicated findings in the addiction psychiatry literature. You can read more about this in our clinical breakdown of cannabis and mental health.

Depression and anxiety show a bidirectional relationship with cannabis use. Many patients begin using cannabis to manage anxiety symptoms, which provides short-term relief through the anxiolytic effects of lower-dose THC. The problem is that chronic heavy use dysregulates the endocannabinoid system and typically worsens baseline anxiety over time, a pattern I see repeatedly in patients who present after years of daily use.

Cannabis Withdrawal Syndrome

Cannabis withdrawal syndrome is now formally recognized in DSM-5 and appears in approximately 47% of regular users who stop abruptly. Symptoms include irritability, anger, anxiety, insomnia, decreased appetite, restlessness, and depressed mood. Onset is typically within 24 to 48 hours of cessation, peaks around days 2 to 6, and resolves in most cases within 2 to 3 weeks. Physical symptoms such as sweating, chills, and headache occur in a subset of patients. Withdrawal is rarely medically dangerous, but it is the primary driver of relapse in the first week, which is why structured support matters.

Cannabis Hyperemesis Syndrome

Cannabis hyperemesis syndrome (CHS) is a condition that was essentially unknown 20 years ago and is now a recognized clinical presentation in emergency departments. It involves cyclical episodes of severe nausea and vomiting in chronic heavy cannabis users, paradoxically, since many patients initially use cannabis for its antiemetic properties. The mechanism is not fully understood but involves CB1 receptor overstimulation and possible dysregulation of the hypothalamic thermoregulatory system. Emergency department presentations for CHS have increased significantly in states following legalization.

Respiratory and Cardiovascular Effects

Smoked cannabis contains many of the same combustion byproducts as tobacco, including carbon monoxide, tar, and benzene. Regular smoking is associated with chronic bronchitis, increased respiratory infections, and airway inflammation. The cardiovascular data shows a roughly 4.8-fold increased risk of myocardial infarction in the first hour after smoking cannabis in people with pre-existing cardiac risk factors, driven by acute increases in heart rate and blood pressure alongside CB1-mediated vasospasm.

Marijuana Legalization Statistics and Changing Perceptions

As of 2024, 24 US states and Washington DC have legalized recreational marijuana. Another 14 states allow medical use. The legal and regulatory landscape has shifted faster than the public health infrastructure supporting it.

Public risk perception has moved inversely to use rates. The share of high school seniors who view regular marijuana use as dangerous dropped from 58% in 2000 to 36% in 2024. Among adults, 64% say regular alcohol use poses a greater health risk than regular marijuana use, and 63% say tobacco is more harmful. 76% of Americans believe cannabis can treat certain medical conditions.

These perceptions are not entirely wrong. Cannabis does have documented therapeutic applications, including in neuropathic pain, chemotherapy-induced nausea, and certain epilepsy syndromes. But the perception that cannabis is essentially harmless for most people does not match the clinical evidence on dependence, mental health, and adolescent neurodevelopment. The 53% of Americans who believe cannabis does not lead to harder drug use are probably correct in the narrow sense that most cannabis users do not progress to heroin or cocaine. But the gateway framework is less relevant than the standalone risks cannabis carries at population scale.

Marijuana Statistics by Demographics: Age, Gender, and Race

Young adults aged 18 to 34 show the highest prevalence of cannabis use across all measures. Men are approximately 1.8 to 2 times more likely than women to use cannabis regularly or daily. The gender gap narrows among younger cohorts, suggesting changing social norms around female cannabis use.

Racial and socioeconomic patterns are significant. Black and Native American populations report higher rates of frequent cannabis use than white populations in most national surveys, despite similar or lower rates of cannabis use disorder treatment access. Socioeconomic factors including lower income and lower educational attainment correlate with higher frequency of use and earlier age of onset.

Among older adults, use is rising faster than in any other age group. Adults over 65 represent the fastest-growing demographic of new cannabis users in the United States, driven largely by use for pain management and sleep. This carries specific risks: older adults metabolize THC differently, are more likely to be on medications with CYP3A4 interactions, and face higher fall risk from cannabis-related dizziness and coordination impairment.

Marijuana Statistics Compared to Other Drugs

Cannabis is the most used illicit substance by a substantial margin. For context from the broader drug use statistics landscape, here is where it sits relative to other substances.

The fact that direct cannabis overdose fatalities are effectively zero is real, and it matters. But absence of acute overdose lethality should not be read as absence of harm. The population-level burden of cannabis use disorder, psychosis, impaired adolescent development, and driving fatalities represents a substantial public health cost that does not appear in overdose statistics.

There is a clinical pattern I see often: a patient who has been using cannabis daily for several years, has tried to cut back multiple times without lasting success, and whose use has quietly reorganized their life without them fully noticing. Under DSM-5, this is cannabis use disorder, a medical condition, not a character flaw. The criteria do not require physical harm to be present. Psychological dependence, compulsive use despite relationship problems, declining occupational function, and tolerance that requires steadily higher-potency products all count. If two or more of the eleven DSM-5 criteria apply over the past year, a clinical assessment is warranted.

At Phuket Island Rehab, we treat cannabis use disorder as a primary diagnosis, not an afterthought. Our programme includes medical assessment, structured withdrawal support where indicated, evidence-based therapy addressing the underlying patterns that sustain use, and aftercare planning built around the person’s actual life, not a generic checklist. Many of our cannabis patients have tried to stop on their own repeatedly. Structured residential treatment in a removed environment changes the outcome for most of them.

Cannabis is the world’s most widely used controlled substance, with 228 million global users and over 64 million past-year users in the United States alone. The trajectory over the past decade is clear: use is up, potency is dramatically higher, and rates of cannabis use disorder have risen faster than use rates themselves. Roughly 30% of regular users will meet DSM-5 criteria for cannabis use disorder, a figure that climbs to around 50% among daily users. Youth remain the highest-risk group, not because more teenagers are using cannabis today than a decade ago, but because the products available are far more potent and the neurological consequences of adolescent-onset use are well established. The mental health data, particularly on psychosis, anxiety, and cognitive development, represent the most clinically significant findings in the current evidence base.

The practical takeaway is this: the numbers that matter most are not total users, but frequency, age of onset, and product potency. A person who tries cannabis twice in college carries a fundamentally different risk profile than someone using daily-use high-THC concentrates starting at age 15. Cannabis withdrawal syndrome is real and drives early relapse. Cannabis use disorder responds well to structured treatment. And the perception gap between public risk assessment and clinical evidence is wider for cannabis than for almost any other substance in common use today.

As John A. Smith of Phuket Island Rehab puts it: “The patients I worry about most aren’t the ones who admit they have a problem. They’re the ones who used to run five times a week, used to call their parents back, used to have a plan for their career. Cannabis didn’t cause a crisis they could point to. It just quietly replaced everything else, one evening at a time. That’s not a low-risk pattern, regardless of what the legalization debate says about the drug.”

How many people use marijuana worldwide?

Approximately 228 million people used cannabis globally in 2023, according to the UNODC, representing around 4.5% of the world’s adult population aged 15 to 64. This makes cannabis the most widely used controlled substance on earth by a substantial margin. Use is highest in North America, Western Europe, and Australia, and has grown in all three regions over the past decade.

What percentage of marijuana users become addicted?

Approximately 30% of regular cannabis users will develop cannabis use disorder, the clinical term for addiction to marijuana under DSM-5. Among daily users, that figure rises to approximately 50%. The risk is not evenly distributed: users who start before age 18 face 4 to 7 times the risk of those who begin in adulthood, and high-potency products accelerate the development of tolerance and dependence.

Is marijuana use increasing or decreasing in the United States?

Overall adult marijuana use has increased significantly over the past decade, rising approximately 65% between 2015 and 2024. Among adolescents, the picture is more mixed: lifetime use among 12th-graders has declined by 20.4% over the past five years, but daily use rates have remained broadly stable, and the potency of products being used has risen sharply. Rates of cannabis use disorder have risen 3.7-fold since 2015, faster than use rates alone would predict.

What are the mental health effects of regular marijuana use?

Regular cannabis use is associated with a 2-fold increased risk of psychosis, with the relationship being dose-dependent, meaning more frequent use and higher-potency products amplify the risk. It is also associated with worsening anxiety and depression over time, despite short-term anxiolytic effects at lower doses. Adolescents who use cannabis regularly show documented IQ reductions of 5 to 8 points in longitudinal studies, an effect that does not fully reverse with abstinence in some cohorts. The full clinical picture of cannabis and mental health is more detailed than most people expect.

What is cannabis use disorder and how is it diagnosed?

Cannabis use disorder is the DSM-5 diagnosis for problematic cannabis use that causes clinically significant impairment or distress. It is diagnosed when two or more of eleven specified criteria are met within a 12-month period: these include tolerance, withdrawal, using more than intended, failed efforts to cut down, significant time spent obtaining or recovering from cannabis use, cravings, and continued use despite physical, psychological, or social harm. Two to three criteria equals mild CUD, four to five is moderate, and six or more is severe. It is a medical diagnosis, not a moral judgment.

Can you go through withdrawal from marijuana?

Yes. Cannabis withdrawal syndrome is recognized in DSM-5 and occurs in roughly 47% of regular users who stop abruptly. Symptoms include irritability, anxiety, insomnia, decreased appetite, restlessness, and depressed mood, typically beginning within 24 to 48 hours and peaking around days 2 to 6. It is rarely medically dangerous, but it is uncomfortable enough that it drives most early relapse attempts. Structured support during the withdrawal period significantly improves outcomes. You can find a detailed clinical breakdown at our page on cannabis withdrawal syndrome.

How does marijuana use compare to other drugs in terms of addiction risk?

Cannabis has a lower dependence rate per user than heroin, cocaine, or nicotine, but it has a far larger user base, which means the absolute number of people with cannabis use disorder is very high, approximately 16.4 million Americans in 2024. Unlike opioids or stimulants, cannabis does not produce fatal overdose, which is a genuine distinction. That said, the combination of a 30% dependence rate among regular users, significant mental health risks, and documented adolescent neurodevelopmental harm makes it a serious public health concern regardless of its relatively benign profile in overdose statistics.